Beatrice Greco
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
N-glycans in non-malignant tumor microenvironment cells dampen CAR-T cell function in solid tumors.
Journal: Journal for immunotherapy of cancer
Published: July 29, 2026
Systemic delivery of cadherin 17-specific CAR T cells allows effective and safe targeting of colorectal cancer liver metastases.
Journal: Science translational medicine
Published: May 28, 2025
CD4 CAR-T cells targeting CD19 play a key role in exacerbating cytokine release syndrome, while maintaining long-term responses.
Journal: Journal for immunotherapy of cancer
Published: December 10, 2022
Time 2EVOLVE: predicting efficacy of engineered T-cells - how far is the bench from the bedside?
Journal: Journal for immunotherapy of cancer
Published: April 07, 2022
Disrupting N-glycan expression on tumor cells boosts chimeric antigen receptor T cell efficacy against solid malignancies.
Journal: Science translational medicine
Published: January 19, 2022
Expression of inducible factors reprograms CAR-T cells for enhanced function and safety.
Journal: Cancer cell
Published: April 26, 2021
CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome.
Journal: The Journal of clinical investigation
Published: April 23, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026